SCHEMBL30734149

SCHEMBL30734149

Brc1ccc2ncnc(N3[C@@H]4CC[C@H]3CN(c3ccccn3)C4)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.47
NPSR1 Q6W5P4 3/20 0.45
ALDH1A1 P00352 3/20 0.45
ACHE P22303 1/20 0.44
BACE1 P56817 1/20 0.44
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
IRAK4 Q9NWZ3 3/20 0.40
PDGFRB P09619 1/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30734194 0.82 HTT (0.66) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734138 0.81 IRAK4 (0.46) ALDH1A1ACHEBACE1HTR1AHTR7
SCHEMBL30734234 0.80 SMN1; SMN2 (0.47) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734133 0.80 SMN1; SMN2 (0.47) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734214 0.79 HTT (0.62) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734146 0.78 HTT (0.52) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734193 0.78 HTT (0.52) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734200 0.78 HTT (0.54) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734183 0.78 HTT (0.51) HTTNPSR1ALDH1A1ACHEBACE1
SCHEMBL30734135 0.70 HTT (0.71) HTTNPSR1ALDH1A1ACHEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed
EP-4543888-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF Arizona Board of Regents on behalf of The University of Arizona (US) 2025-04-30 EP disclosed
WO-2023250083-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 HTT 713/4885NPSR1 1834/4885ALDH1A1 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.